Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

89bio, Inc. - Common Stock (NQ:ETNB)

14.84 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 89bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Nasdaq Edges Higher; Crude Oil Rises 1% ↗
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite moving higher on Wednesday. The Dow traded down 0.15% to 32,512.83 while the NASDAQ rose 0.13% to 11,875.36. The S&P 500, also... 
Via Benzinga
89Bio Inc. (NASDAQ: ETNB) Near the Top of Equities by Percentage Gain on 3/22
Via Investor Brand Network
News headline image
89bio (NASDAQ: ETNB) Reports Phase 2b ENLIVEN Trial of Pegozafermin Achieved Primary Endpoints For Treatment of Nonalcoholic Steatohepatitis (NASH)
89bio, Inc. (NASDAQ: ETNB) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development of 
Via Spotlight Growth
News headline image
Why Are Meme Stocks GME, AMC, BBBY Up Today? ↗
Meme stocks are on the move Wednesday as investors celebrate a recent earnings report from GameStop (GME) with a surprise profit. 
Via InvestorPlace
News headline image
Travelzoo, Semler Scientific, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded mostly higher, with the Dow Jones gaining around 20 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Analyst Ratings for 89bio ↗
 
Via Benzinga
News headline image
SSYS Stock Alert: Stratasys Rejects Nano Dimension’s Takeover Offer ↗
Stratasys (SSYS) stock is on the move Wednesday after the company rejected a $1.1 billion takeover offer from Nano Dimension. 
Via InvestorPlace
News headline image
US Stocks Edge Lower Ahead Of Fed Decision; Nike Earnings Top Estimates ↗
U.S. stocks traded slightly lower this morning. The Federal Reserve is scheduled to conclude a two-day policy meeting today, with markets expecting a 25 basis-point rate hike. Following the market... 
Via Benzinga
News headline image
LAZR Stock Price Predictions: Why This Analyst Says Luminar Is Worth Just $5 ↗
Luminar (LAZR) stock is taking a beating on Wednesday as a new rating and price prediction weigh on the company's shares. 
Via InvestorPlace
News headline image
Why Is 89bio (ETNB) Stock Up 34% Today? ↗
89bio (ETNB) stock is taking off on Wednesday after the company posted results from a Phase 2b clinical trial of pegozafermin. 
Via InvestorPlace
News headline image
89bio Rockets 30% — And Akero Dives — On A Scorching Battle In Liver Disease ↗
The battle pits 89bio and Akero in nonalcoholic steatohepatitis. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
89bio’s Phase 2b ENLIVEN Trial of Pegozafermin in Nonalcoholic Steatohepatitis (NASH) Achieved High Statistical Significance on Both Primary Histology Endpoints with Weekly (QW) and Every-Two-Week (Q2W) Dosing at 24 Weeks
From 89bio, Inc.
Via GlobeNewswire
News headline image
Charles Schwab To Rally Over 19%? Here Are 10 Other Analyst Forecasts For Monday ↗
HC Wainwright & Co. cut the price target for 89bio, Inc. (NASDAQ: ETNB) from $27 to $25. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. 89bio shares fell 5.2% to trade at $11.80 on... 
Via Benzinga
News headline image
89bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Presents New Analysis of Data from Phase 2 ENTRIGUE Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) at American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology
From 89bio, Inc.
Via GlobeNewswire
News headline image
DraftKings To Rally Around 38%? Here Are 10 Other Analyst Forecasts For Tuesday ↗
Wells Fargo boosted the price target for Deere & Company (NYSE: DE) from $485 to $510. Wells Fargo analyst Seth Weber maintained an Overweight rating on the stock. Deere shares fell 0.5% to $431.08 in... 
Via Benzinga
News headline image
89bio to Present Additional Pegozafermin Data in Severe Hypertriglyceridemia from Phase 2 ENTRIGUE Study at American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio to Participate in the SVB Securities Global Biopharma Conference
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Provides Business Update and Outlook for 2023
From 89bio, Inc.
Via GlobeNewswire
News headline image
20 Favorite Biotech & Medical Stocks For 2023 ↗
The way these stocks are setting up, many of them look great and will be at the forefront this coming year. 
Via Talk Markets
News headline image
US Stocks Slightly Lower; Nasdaq Down 100 Points ↗
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 100 points on Monday. 
Via Benzinga
News headline image
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
89bio Announces Publication of Results of Phase 1b/2a Study of Pegozafermin for the Treatment of NASH in The Lancet Gastroenterology & Hepatology
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From 89bio, Inc.
Via GlobeNewswire
News headline image
89bio Presents Additional Exploratory Analyses from the Phase 1b/2a NASH Study of Pegozafermin at AASLD The Liver Meeting® 2022
From 89bio, Inc.
Via GlobeNewswire
News headline image
ServiceNow, Teladoc Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded mostly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
$9 Million Bet On 89bio? 3 Stocks Insiders Are Buying ↗
Although US stocks closed lower on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
AVEO Pharmaceuticals, Akouos And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.